Insider Trading March 27, 2026

Castellum COO Adds 2,000 Shares as Company Cleans Up Balance Sheet and Wins Large Contract

Andrew Merriman buys $1,285 of CTM stock while the company reports zero debt, increased cash and a $49.8M contract for its subsidiary

By Caleb Monroe CTM
Castellum COO Adds 2,000 Shares as Company Cleans Up Balance Sheet and Wins Large Contract
CTM

Castellum, Inc. Chief Operating Officer Andrew Merriman purchased 2,000 shares of the company on March 27, 2026, for $0.6426 per share, a transaction valued at $1,285. The trade leaves Merriman with 536,000 shares directly held. The purchase coincides with the stock trading near its 52-week low and recent weekly weakness. Separately, Castellum has fully retired its last note payable, moving from more than $11 million in debt in July 2024 to zero debt and over $14 million in cash, and its subsidiary Specialty Systems, Inc. secured a $49.8 million continuation contract with the Naval Air Warfare Center Aircraft Division Lakehurst. Canterra Minerals also announced a board appointment unrelated to Castellum.

Key Points

  • Castellum COO Andrew Merriman purchased 2,000 shares on March 27, 2026 at $0.6426 per share, totaling $1,285, and now directly owns 536,000 shares.
  • The stock is trading near a 52-week low of $0.65 and was quoted at $0.62, down 12.6% over the last week.
  • Castellum has retired its last note payable of $400,000, transitioning from over $11 million in debt and about $2 million in cash in July 2024 to zero debt and more than $14 million in cash; its subsidiary SSI secured a $49.8 million contract with NAWCAD Lakehurst.

Chief Operating Officer Andrew Merriman of Castellum, Inc. reported a personal purchase of 2,000 shares of the companys common stock on March 27, 2026, at a price of $0.6426 per share. The disclosed transaction totaled $1,285. Following the trade, Merriman directly holds 536,000 shares of Castellum.

The insider purchase takes place as the stock trades near its 52-week low of $0.65 and was quoted at $0.62 at the time of the report. That price level reflects a 12.6% decline over the prior week, according to the information released alongside the filing.

Analysis cited in the disclosure notes that the stock appears undervalued at current levels, with analysts forecasting a return to profitability this year. The report points investors to a Pro Research Report on CTM for more detailed coverage, one among the suite of reports available for U.S. equities.


Balance sheet movement and cash position

In corporate filings, Castellum announced it has fully retired the $400,000 principal balance on its last remaining note payable. The company described this step as the end of its debt elimination process. The filings show a marked change in the companys financial position compared with July 2024, when Castellum reported carrying over $11 million in debt and roughly $2 million in cash. Current disclosures indicate the company now has no debt and more than $14 million in cash.


Contract win for subsidiary

Castellum also confirmed that its subsidiary, Specialty Systems, Inc., secured a $49.8 million contract to provide software support for the Naval Air Warfare Center Aircraft Division Lakehurst. The company described the award as a continuation of existing work with NAWCAD Lakehurst and noted it is the third consecutive contract win for SSI on this account.


Separate board change at Canterra Minerals

Also reported in the corporate notices was a governance change at Canterra Minerals Corporation. Matt Manson has been appointed to Canterras Board of Directors following the retirement of Michael Power. The filing describes Manson as a veteran of the mining industry with experience from leadership roles at Radisson Mining Resources Inc. and Marathon Gold Corporation.


Takeaway

The disclosures combine a modest insider purchase with material corporate developments: elimination of the companys remaining debt, a strengthened cash position, and a substantial service contract for a subsidiary focused on defense-related software support. Separately, the filing documents a board appointment at Canterra Minerals. The report also references analyst views and a Pro Research Report for investors seeking additional detail.

Risks

  • Share price is close to the 52-week low and has fallen 12.6% over the past week, indicating recent market weakness that may affect investor returns.
  • Analyst expectations of a return to profitability are forward-looking; the companys future profitability is not guaranteed.
  • Despite the elimination of the last note payable, the companys prior history of significant debt reflects past financial stress that may inform investor assessment of risk.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026